The Detection of Heat Stress by Assessing Individual Body Responses to Heat (Heat Strain) in Young and Healthy Non-athlete Participants
Launched by ETH ZURICH · Nov 11, 2022
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy participant, able to give consent
- • Age 18-40 years
- • Non-athlete (\<4h sport/week)
- • BMI\<30 (non-obese)
- • German speaking, or fluent in German
- Exclusion Criteria:
- • Pregnancy (urine pregnancy test), and breastfeeding
- • Regular medication intake (excluding birth control pill)
- • Intake of drugs and/or daily alcohol consumption
- • Fever or symptoms of an acute infection (cough, shortness of breath, sore throat, taste loss)
- • Active smoking or history of smoking \<9 months ago
- • Mobility impairment
- • Traveled (\<1 month ago) to a warm/hot temperature zone and stayed for \>6 days
- • Any chronic conditions such as: high blood pressure, diabetes mellitus, immuno-deficiencies, sweat disorders such as anhidrosis
- • Color blindness (STROOP test)
- • Weight \<40 kg (e-Celsius pill)
- • Diverticulum or obstructions of the gastrointestinal tract (including motility disorders, swallowing disorders) as well as major abdominal surgery (e-Celsius pill)
- • Need of exposure to strong electromagnetic fields during study participation, above all MRI examinations (e-Celsius pill)
About Eth Zurich
ETH Zurich, a prestigious institution known for its cutting-edge research and innovation, is a leading sponsor of clinical trials focused on advancing medical science and improving patient outcomes. With a strong emphasis on interdisciplinary collaboration, ETH Zurich leverages its expertise in engineering, technology, and life sciences to explore novel therapeutic approaches and enhance healthcare delivery. The institution is committed to adhering to rigorous ethical standards and regulatory compliance, ensuring the integrity and scientific validity of its clinical research initiatives. Through its sponsorship, ETH Zurich aims to contribute significantly to the development of transformative treatments and interventions that address critical healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, Andere (Nicht Usa Länder), Switzerland
Patients applied
Trial Officials
Noé Brasier, MD
Principal Investigator
ETH Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials